NEW YORK (GenomeWeb News) – CombiMatrix said today that it has entered into an agreement with Stratose to provide coverage for its menu of diagnostic laboratory services, including its CombiSNP chromosomal microarray test.

Atlanta-based Stratose maintains a large preferred provider organization network in the US, including more than 850,000 direct and affiliate medical, dental, and workers' compensation provider contracts. Members of these plans will now have access to CombiMatrix's suite of tests for use in prenatal, miscarriage, and pediatric healthcare.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.